Santiago Grau

Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study

Luisa Sorlí, Sònia Luque, Santiago Grau et al. · BMC Infectious Diseases · 2013 · 222 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition

Eva Morales, Francesc Cots, María Sala et al. · BMC Health Services Research · 2012 · 172 citations · Full text

Pharmacy, Microbiology, Pharmacoeconomics +17

Eosinophil Count and Neutrophil-Lymphocyte Count Ratio as Prognostic Markers in Patients with Bacteremia: A Retrospective Cohort Study

Roser Terradas, Santiago Grau, Jordi Blanch et al. · PLoS ONE · 2012 · 169 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +14

Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study

Erika Esteve-Palau, G. Solande, F Sánchez et al. · Journal of Infection · 2015 · 118 citations

Pharmacy, Infectious Diseases, Pharmacoeconomics +17

Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections

M. Montero, Juan Pablo Horcajada, Luisa Sorlí et al. · Infection · 2009 · 96 citations

Life Sciences, Infectious Diseases, Microbiology +12